U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07084246) titled 'Evaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center Observational Study' on July 16.
Brief Summary: The purpose of this study is to evaluate the effectiveness and safety of the investigational drug on blood pressure and LDL cholesterol control during the observation period in patients who have undergone percutaneous coronary intervention (PCI) in actual clinical practice.
Study Start Date: June 07, 2023
Study Type: OBSERVATIONAL
Condition:
Hypertension, Dyslipidemia
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: GC Biopharma Corp
Published by HT Digital Content Services with ...